$ARRY Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ARRAY BIOPHARMA INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in ARRAY BIOPHARMA INC. Get notifications about new insider transactions in ARRAY BIOPHARMA INC for free.

Page: < prev 1 ... 2 3 4 5 6 7 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 03 2014	ARRY	ARRAY BIOPHARMA IN ...	Needle Michael N	CMO	Option Exercise	A	4.63	175,000	810,250	175,000
Apr 03 2014	ARRY	ARRAY BIOPHARMA IN ...	Robbins Andrews R	SVP, Commercial Ope ...	Option Exercise	A	4.63	175,000	810,250	175,000
Apr 03 2014	ARRY	ARRAY BIOPHARMA IN ...	Squarer Ron	CEO	Option Exercise	A	4.63	425,000	1,967,750	425,000
Dec 03 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	5.79	11,666	67,546	20	11.7 K to 20 (-99.83 %)
Nov 15 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	5.79	200	1,158	11,686	11.9 K to 11.7 K (-1.68 %)
Oct 25 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Option Exercise	A	5.60	25,000	140,000	25,000
Oct 24 2013	ARRY	ARRAY BIOPHARMA IN ...	Fyfe Gwen A.	Director	Option Exercise	A	5.60	25,000	140,000	25,000
Oct 24 2013	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Option Exercise	A	5.60	25,000	140,000	25,000
Oct 24 2013	ARRY	ARRAY BIOPHARMA IN ...	Orwin John A	Director	Option Exercise	A	5.60	25,000	140,000	25,000
Oct 24 2013	ARRY	ARRAY BIOPHARMA IN ...	VAN LUNSEN GIL J	Director	Option Exercise	A	5.60	25,000	140,000	25,000
Oct 24 2013	ARRY	ARRAY BIOPHARMA IN ...	ZABRISKIE JOHN L	Director	Option Exercise	A	5.60	25,000	140,000	25,000
Sep 30 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Sell	S	5.99	863,521	5,170,764	0	863.5 K to 0 (-100.00 %)
Sep 30 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Sell	S	6.02	262,207	1,578,958	863,521	1.1 M to 863.5 K (-23.29 %)
Sep 16 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Sell	S	6.14	319,033	1,957,650	1,125,728	1.4 M to 1.1 M (-22.08 %)
Sep 16 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Sell	S	6.01	546,660	3,287,668	1,444,761	2 M to 1.4 M (-27.45 %)
Sep 16 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Sell	S	6.10	807,479	4,923,119	1,991,421	2.8 M to 2 M (-28.85 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	3.06	30,000	91,800	30,000
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	3.01	13,884	41,791	9,375
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	3.01	14,241	42,865	23,259
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	2.74	12,500	34,250	12,500
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	7.03	43,884	308,469	11,886	55.8 K to 11.9 K (-78.69 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	3.06	30,000	91,800	55,770	25.8 K to 55.8 K (+116.41 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	3.01	13,884	41,791	25,770	11.9 K to 25.8 K (+116.81 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	7.00	31,500	220,635	11,886	43.4 K to 11.9 K (-72.60 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	3.01	14,241	42,865	43,386	29.1 K to 43.4 K (+48.86 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	2.74	12,500	34,250	29,145	16.6 K to 29.1 K (+75.10 %)
Sep 06 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Sell	S	5.68	139,572	793,202	2,798,900	2.9 M to 2.8 M (-4.75 %)
Sep 06 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Sell	S	5.77	201,598	1,163,523	2,938,472	3.1 M to 2.9 M (-6.42 %)
Sep 06 2013	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Sell	S	5.87	236,116	1,385,623	3,140,070	3.4 M to 3.1 M (-6.99 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Option Exercise	M	3.75	21,357	80,089	0
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Payment of Exercise	F	6.07	15,151	91,967	1,502,358	1.5 M to 1.5 M (-1.00 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Buy	M	3.75	21,357	80,089	1,517,509	1.5 M to 1.5 M (+1.43 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Option Exercise	M	3.75	22,286	83,573	0
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Payment of Exercise	F	6.07	12,365	75,056	784,875	797.2 K to 784.9 K (-1.55 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Buy	M	3.75	22,286	83,573	797,240	775 K to 797.2 K (+2.88 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Option Exercise	M	3.75	15,321	57,454	0
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Payment of Exercise	F	6.07	10,869	65,975	112,265	123.1 K to 112.3 K (-8.83 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Buy	M	3.75	15,321	57,454	123,134	107.8 K to 123.1 K (+14.21 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	3.75	4,759	17,846	0
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	2.74	5,000	13,700	25,000
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	3.75	4,759	17,846	16,645	11.9 K to 16.6 K (+40.04 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	6.50	5,000	32,500	11,886	16.9 K to 11.9 K (-29.61 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	2.74	5,000	13,700	16,886	11.9 K to 16.9 K (+42.07 %)
May 07 2013	ARRY	ARRAY BIOPHARMA IN ...	Squarer Ron	Chief Executive Off ...	Option Exercise	A	5.94	350,000	2,079,000	350,000
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	2.74	20,000	54,800	30,000
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	D	6.52	20,000	130,400	11,886	31.9 K to 11.9 K (-62.72 %)
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	2.74	20,000	54,800	31,886	11.9 K to 31.9 K (+168.27 %)
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	2.74	20,000	54,800	30,000
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	D	6.52	20,000	130,400	11,886	31.9 K to 11.9 K (-62.72 %)
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	2.74	20,000	54,800	31,886	11.9 K to 31.9 K (+168.27 %)
Apr 01 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	4.91	80,000	392,800	80,000
Apr 01 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	4.91	80,000	392,800	80,000
Apr 01 2013	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Option Exercise	A	4.91	110,000	540,100	110,000
Apr 01 2013	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Option Exercise	A	4.91	95,000	466,450	95,000
Apr 01 2013	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Option Exercise	A	4.91	120,000	589,200	120,000
Oct 26 2012	ARRY	ARRAY BIOPHARMA IN ...	Ratcliffe Liam	Director	Option Exercise	A	4.36	20,000	87,200	20,000
Oct 26 2012	ARRY	ARRAY BIOPHARMA IN ...	ZABRISKIE JOHN L	Director	Option Exercise	A	4.36	20,000	87,200	20,000
Oct 26 2012	ARRY	ARRAY BIOPHARMA IN ...	VAN LUNSEN GIL J	Director	Option Exercise	A	4.36	20,000	87,200	20,000
Oct 26 2012	ARRY	ARRAY BIOPHARMA IN ...	Fyfe Gwen A.	Director	Option Exercise	A	4.36	20,000	87,200	20,000
Oct 26 2012	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Option Exercise	A	4.36	20,000	87,200	20,000
Oct 26 2012	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Gift	G	0.00	1,000	0	3,585	4.6 K to 3.6 K (-21.81 %)
Oct 09 2012	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	5.69	2,357	13,401	0	2.4 K to 0 (-100.00 %)
Oct 09 2012	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	5.69	26,190	148,911	11,886	38.1 K to 11.9 K (-68.78 %)
Oct 05 2012	ARRY	ARRAY BIOPHARMA IN ...	Squarer Ron	CEO	Grant	A	0.00	4,397	0	4,397	0 to 4.4 K
Oct 05 2012	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Grant	A	0.00	16,975	0	1,496,152	1.5 M to 1.5 M (+1.15 %)
Oct 05 2012	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	11,886	0	38,076	26.2 K to 38.1 K (+45.38 %)
Oct 05 2012	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Grant	A	0.00	22,718	0	774,954	752.2 K to 775 K (+3.02 %)
Oct 05 2012	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Grant	A	0.00	11,391	0	105,961	94.6 K to 106 K (+12.05 %)
Apr 27 2012	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Option Exercise	A	3.69	25,000	92,250	25,000
Apr 27 2012	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Gift	G	0.00	5,415	0	30,000	24.6 K to 30 K (+22.03 %)
Apr 27 2012	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Gift	G	0.00	5,415	0	4,585	10 K to 4.6 K (-54.15 %)
Apr 03 2012	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Option Exercise	A	3.40	75,000	255,000	75,000
Apr 03 2012	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	3.40	75,000	255,000	75,000
Apr 03 2012	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Option Exercise	A	3.40	90,000	306,000	90,000
Apr 03 2012	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Option Exercise	A	3.40	90,000	306,000	90,000
Feb 10 2012	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.65	1,545	4,094	94,570	96.1 K to 94.6 K (-1.61 %)
Feb 09 2012	ARRY	ARRAY BIOPHARMA IN ...	Fyfe Gwen A.	Director	Option Exercise	A	2.60	20,000	52,000	20,000
Jan 12 2012	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.06	1,994	4,108	96,115	98.1 K to 96.1 K (-2.03 %)
Dec 12 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.35	1,743	4,096	96,295	98 K to 96.3 K (-1.78 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.14	2,700	5,775	4,893,000	4.9 M to 4.9 M (+0.06 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.14	600	1,283	1,050,900	1.1 M to 1.1 M (+0.06 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.14	1,000	2,139	1,715,269	1.7 M to 1.7 M (+0.06 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.10	20,500	43,034	4,890,300	4.9 M to 4.9 M (+0.42 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.10	4,400	9,236	1,050,300	1 M to 1.1 M (+0.42 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.10	7,200	15,114	1,714,269	1.7 M to 1.7 M (+0.42 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.04	56,400	115,163	4,869,800	4.8 M to 4.9 M (+1.17 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.04	9,200	18,785	1,045,900	1 M to 1 M (+0.89 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.04	17,600	35,937	1,707,069	1.7 M to 1.7 M (+1.04 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.21	38,000	84,029	4,813,400	4.8 M to 4.8 M (+0.80 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.21	11,000	24,324	1,036,700	1 M to 1 M (+1.07 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.21	15,253	33,729	1,689,469	1.7 M to 1.7 M (+0.91 %)
Nov 14 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.47	1,656	4,090	98,038	99.7 K to 98 K (-1.66 %)
Oct 27 2011	ARRY	ARRAY BIOPHARMA IN ...	VAN LUNSEN GIL J	Director	Option Exercise	A	2.46	20,000	49,200	20,000
Oct 27 2011	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Option Exercise	A	2.46	20,000	49,200	20,000
Oct 27 2011	ARRY	ARRAY BIOPHARMA IN ...	BULLOCK FRANCIS J	Director	Option Exercise	A	2.46	20,000	49,200	20,000
Oct 12 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.08	1,977	4,112	99,694	101.7 K to 99.7 K (-1.94 %)
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	2,357	0	2,357	0 to 2.4 K
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	26,190	0	26,190	0 to 26.2 K
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Gift	G	0.00	456,473	0	1,935,650	1.5 M to 1.9 M (+30.86 %)
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Gift	G	0.00	456,473	0	0	456.5 K to 0 (-100.00 %)
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Grant	A	0.00	37,414	0	1,479,177	1.4 M to 1.5 M (+2.60 %)
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Grant	A	0.00	50,271	0	752,236	702 K to 752.2 K (+7.16 %)
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Grant	A	0.00	24,693	0	101,671	77 K to 101.7 K (+32.08 %)
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	CONWAY ROBERT	CEO	Grant	A	0.00	57,190	0	633,386	576.2 K to 633.4 K (+9.93 %)
Sep 14 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.02	2,034	4,109	76,978	79 K to 77 K (-2.57 %)
Aug 16 2011	ARRY	ARRAY BIOPHARMA IN ...	CARUTHERS MARVIN H	Director	Sell	S	2.14	2,300	4,922	269,040	271.3 K to 269 K (-0.85 %)
Aug 15 2011	ARRY	ARRAY BIOPHARMA IN ...	CARUTHERS MARVIN H	Director	Gift	G	0.00	88,437	0	177,763	89.3 K to 177.8 K (+99.00 %)
Aug 15 2011	ARRY	ARRAY BIOPHARMA IN ...	CARUTHERS MARVIN H	Director	Gift	G	0.00	88,437	0	271,340	359.8 K to 271.3 K (-24.58 %)
Aug 15 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.26	1,810	4,091	79,012	80.8 K to 79 K (-2.24 %)
Aug 11 2011	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Buy	P	2.22	5,000	11,100	15,000	10 K to 15 K (+50.00 %)
Jul 12 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.50	1,638	4,095	80,822	82.5 K to 80.8 K (-1.99 %)
Jun 17 2011	ARRY	ARRAY BIOPHARMA IN ...	CONWAY ROBERT	CEO	Buy	P	2.17	25,000	54,250	576,196	551.2 K to 576.2 K (+4.54 %)
Jun 13 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.38	1,720	4,094	82,460	84.2 K to 82.5 K (-2.04 %)
May 16 2011	ARRY	ARRAY BIOPHARMA IN ...	CONWAY ROBERT	CEO	Buy	P	2.86	20,000	57,200	551,196	531.2 K to 551.2 K (+3.77 %)
Apr 12 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	3.04	1,340	4,074	85,664	87 K to 85.7 K (-1.54 %)
May 12 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.75	1,484	4,081	84,180	85.7 K to 84.2 K (-1.73 %)
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	3.06	1,250	3,825	1,250
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	3.06	60,000	183,600	60,000
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Option Exercise	A	3.06	60,000	183,600	60,000
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Option Exercise	A	3.06	75,000	229,500	75,000
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Option Exercise	A	3.06	75,000	229,500	75,000
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	CONWAY ROBERT	CEO	Option Exercise	A	3.06	100,000	306,000	100,000
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.30	356	1,175	0	356 to 0 (-100.00 %)
Mar 16 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	3.11	1,310	4,074	87,004	88.3 K to 87 K (-1.48 %)
Feb 11 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	2.91	1,403	4,083	88,314	89.7 K to 88.3 K (-1.56 %)
Jan 13 2011	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	3.20	1,272	4,070	89,717	91 K to 89.7 K (-1.40 %)
Jan 12 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.30	2,366	7,808	356	2.7 K to 356 (-86.92 %)
Jan 12 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.30	593	1,957	2,722	3.3 K to 2.7 K (-17.89 %)
Jan 06 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.25	24,039	78,127	0	24 K to 0 (-100.00 %)
Dec 10 2010	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	3.24	1,256	4,069	89,650	90.9 K to 89.7 K (-1.38 %)
Nov 18 2010	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Sell	S	3.17	2,000	6,340	10,000	12 K to 10 K (-16.67 %)
Nov 18 2010	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Sell	S	3.28	3,000	9,840	12,000	15 K to 12 K (-20.00 %)
Nov 18 2010	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Sell	S	3.31	5,000	16,550	15,000	20 K to 15 K (-25.00 %)
Nov 18 2010	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Gift	G	0.00	4,000	0	24,585	20.6 K to 24.6 K (+19.43 %)
Nov 18 2010	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Gift	G	0.00	4,000	0	20,000	24 K to 20 K (-16.67 %)
Nov 12 2010	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	3.33	1,220	4,063	90,906	92.1 K to 90.9 K (-1.32 %)
Nov 08 2010	ARRY	ARRAY BIOPHARMA IN ...	ZABRISKIE JOHN L	Director	Option Exercise	A	3.51	20,000	70,200	20,000
Nov 08 2010	ARRY	ARRAY BIOPHARMA IN ...	WILLIAMS DOUGLAS E	Director	Option Exercise	A	3.51	20,000	70,200	20,000
Nov 08 2010	ARRY	ARRAY BIOPHARMA IN ...	VAN LUNSEN GIL J	Director	Option Exercise	A	3.51	20,000	70,200	20,000
Nov 08 2010	ARRY	ARRAY BIOPHARMA IN ...	LEFKOFF KYLE	Director	Option Exercise	A	3.51	20,000	70,200	20,000
Nov 08 2010	ARRY	ARRAY BIOPHARMA IN ...	CARUTHERS MARVIN H	Director	Option Exercise	A	3.51	20,000	70,200	20,000
Nov 08 2010	ARRY	ARRAY BIOPHARMA IN ...	BULLOCK FRANCIS J	Director	Option Exercise	A	3.51	20,000	70,200	20,000
Oct 13 2010	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Sell	S	3.32	1,225	4,067	92,126	93.4 K to 92.1 K (-1.31 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	SNITMAN DAVID	COO and VP, Busines ...	Grant	A	0.00	35,106	0	985,290	950.2 K to 985.3 K (+3.69 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.29	20,067	66,020	24,039	44.1 K to 24 K (-45.50 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	2,065	0	3,315	1.3 K to 3.3 K (+165.20 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	24,039	0	44,106	20.1 K to 44.1 K (+119.79 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	KOCH KEVIN	President, CSO	Grant	A	0.00	48,033	0	701,965	653.9 K to 702 K (+7.35 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	CONWAY ROBERT	CEO	Grant	A	0.00	57,474	0	528,996	471.5 K to 529 K (+12.19 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	CARRUTHERS MICHAEL	CFO	Grant	A	0.00	22,998	0	93,351	70.4 K to 93.4 K (+32.69 %)

Page: < prev 1 ... 2 3 4 5 6 7 next >